CD8A and neoplasm: Not only did the DC vaccine induce increased IFN-γ levels in all six mice (compared to four of six mice in the control vaccine), but the DC vaccine also demonstrated higher CD8+ IFN-γ-positive tumor infiltrating cells in five of six mice (compared to two of six mice for the adjuvant group) [24].